KANZHUN LTD - ADR (BZ) Fundamental Analysis & Valuation

NASDAQ:BZ • US48553T1060

Current stock price

13.52 USD
+0.04 (+0.3%)
At close:
13.52 USD
0 (0%)
After Hours:

This BZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. BZ Profitability Analysis

1.1 Basic Checks

  • In the past year BZ was profitable.
  • Of the past 5 years BZ 4 years were profitable.
  • BZ had a positive operating cash flow in 4 of the past 5 years.
BZ Yearly Net Income VS EBIT VS OCF VS FCFBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 11.13%, BZ belongs to the top of the industry, outperforming 84.88% of the companies in the same industry.
  • BZ has a Return On Equity of 13.62%. This is in the better half of the industry: BZ outperforms 63.95% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 10.34%, BZ is in the better half of the industry, outperforming 68.60% of the companies in the same industry.
  • BZ had an Average Return On Invested Capital over the past 3 years of 6.85%. This is significantly below the industry average of 13.11%.
  • The last Return On Invested Capital (10.34%) for BZ is above the 3 year average (6.85%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.13%
ROE 13.62%
ROIC 10.34%
ROA(3y)8.49%
ROA(5y)3.43%
ROE(3y)10.82%
ROE(5y)4.36%
ROIC(3y)6.85%
ROIC(5y)N/A
BZ Yearly ROA, ROE, ROICBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • With an excellent Profit Margin value of 33.09%, BZ belongs to the best of the industry, outperforming 97.67% of the companies in the same industry.
  • In the last couple of years the Profit Margin of BZ has grown nicely.
  • BZ has a Operating Margin of 29.80%. This is amongst the best in the industry. BZ outperforms 94.19% of its industry peers.
  • With an excellent Gross Margin value of 85.06%, BZ belongs to the best of the industry, outperforming 95.35% of the companies in the same industry.
  • BZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.8%
PM (TTM) 33.09%
GM 85.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y140.57%
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y-0.6%
BZ Yearly Profit, Operating, Gross MarginsBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BZ Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BZ is creating some value.
  • Compared to 1 year ago, BZ has about the same amount of shares outstanding.
  • BZ has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for BZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BZ Yearly Shares OutstandingBZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
BZ Yearly Total Debt VS Total AssetsBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • There is no outstanding debt for BZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.37
WACC7.54%
BZ Yearly LT Debt VS Equity VS FCFBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B

2.3 Liquidity

  • BZ has a Current Ratio of 4.66. This indicates that BZ is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.66, BZ belongs to the best of the industry, outperforming 93.02% of the companies in the same industry.
  • BZ has a Quick Ratio of 4.66. This indicates that BZ is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.66, BZ belongs to the top of the industry, outperforming 93.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 4.66
BZ Yearly Current Assets VS Current LiabilitesBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. BZ Growth Analysis

3.1 Past

  • BZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.83%, which is quite impressive.
  • Measured over the past years, BZ shows a very strong growth in Earnings Per Share. The EPS has been growing by 64.44% on average per year.
  • The Revenue has grown by 12.40% in the past year. This is quite good.
  • BZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.57% yearly.
EPS 1Y (TTM)31.83%
EPS 3Y64.44%
EPS 5YN/A
EPS Q2Q%20.25%
Revenue 1Y (TTM)12.4%
Revenue growth 3Y22.38%
Revenue growth 5Y33.57%
Sales Q2Q%13.98%

3.2 Future

  • Based on estimates for the next years, BZ will show a very negative growth in Earnings Per Share. The EPS will decrease by -10.22% on average per year.
  • The Revenue is expected to grow by 10.73% on average over the next years. This is quite good.
EPS Next Y14.65%
EPS Next 2Y15.96%
EPS Next 3Y13.87%
EPS Next 5Y-10.22%
Revenue Next Year12.66%
Revenue Next 2Y12.72%
Revenue Next 3Y12.41%
Revenue Next 5Y10.73%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BZ Yearly Revenue VS EstimatesBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
BZ Yearly EPS VS EstimatesBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. BZ Valuation Analysis

4.1 Price/Earnings Ratio

  • BZ is valuated reasonably with a Price/Earnings ratio of 11.86.
  • 76.74% of the companies in the same industry are more expensive than BZ, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of BZ to the average of the S&P500 Index (26.17), we can say BZ is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 10.34, the valuation of BZ can be described as very reasonable.
  • BZ's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BZ is cheaper than 76.74% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.05. BZ is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.86
Fwd PE 10.34
BZ Price Earnings VS Forward Price EarningsBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BZ Per share dataBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of BZ may justify a higher PE ratio.
  • A more expensive valuation may be justified as BZ's earnings are expected to grow with 13.87% in the coming years.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y15.96%
EPS Next 3Y13.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. BZ Dividend Analysis

5.1 Amount

  • BZ has a Yearly Dividend Yield of 1.13%.
  • The stock price of BZ dropped by -35.34% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 1.86, BZ pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 1.13, BZ pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.13%

5.2 History

  • BZ has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BZ Yearly Dividends per shareBZ Yearly Dividends per shareYearly Dividends per share 2023 2025 0.05 0.1 0.15

5.3 Sustainability

DPN/A
EPS Next 2Y15.96%
EPS Next 3Y13.87%
BZ Yearly Income VS Free CF VS DividendBZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

More info and screens

Find the best dividend stocksShow peers with best dividend

BZ Fundamentals: All Metrics, Ratios and Statistics

KANZHUN LTD - ADR

NASDAQ:BZ (4/2/2026, 8:11:13 PM)

After market: 13.52 0 (0%)

13.52

+0.04 (+0.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)03-18
Earnings (Next)05-20
Inst Owners80.94%
Inst Owner Change0%
Ins Owners0.07%
Ins Owner Change14.7%
Market Cap6.29B
Revenue(TTM)8.27B
Net Income(TTM)2.74B
Analysts84.29
Price Target22.46 (66.12%)
Short Float %7.99%
Short Ratio3.76
Dividend
Industry RankSector Rank
Dividend Yield 1.13%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.59%
Min EPS beat(2)-4.52%
Max EPS beat(2)1.34%
EPS beat(4)3
Avg EPS beat(4)3.53%
Min EPS beat(4)-4.52%
Max EPS beat(4)10.26%
EPS beat(8)6
Avg EPS beat(8)5.45%
EPS beat(12)10
Avg EPS beat(12)14.38%
EPS beat(16)13
Avg EPS beat(16)205.94%
Revenue beat(2)0
Avg Revenue beat(2)-2.63%
Min Revenue beat(2)-3.08%
Max Revenue beat(2)-2.19%
Revenue beat(4)0
Avg Revenue beat(4)-2.29%
Min Revenue beat(4)-3.08%
Max Revenue beat(4)-1.62%
Revenue beat(8)0
Avg Revenue beat(8)-2.09%
Revenue beat(12)3
Avg Revenue beat(12)-1.34%
Revenue beat(16)3
Avg Revenue beat(16)-1.33%
PT rev (1m)-15.91%
PT rev (3m)-15.91%
EPS NQ rev (1m)-0.54%
EPS NQ rev (3m)-0.54%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)-0.11%
Revenue NQ rev (1m)-5.44%
Revenue NQ rev (3m)-5.44%
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 11.86
Fwd PE 10.34
P/S 5.25
P/FCF N/A
P/OCF N/A
P/B 2.16
P/tB 2.17
EV/EBITDA N/A
EPS(TTM)1.14
EY8.43%
EPS(NY)1.31
Fwd EY9.68%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.58
BVpS6.26
TBVpS6.23
PEG (NY)0.81
PEG (5Y)N/A
Graham Number12.67
Profitability
Industry RankSector Rank
ROA 11.13%
ROE 13.62%
ROCE 12.2%
ROIC 10.34%
ROICexc 830.94%
ROICexgc 1450.91%
OM 29.8%
PM (TTM) 33.09%
GM 85.06%
FCFM N/A
ROA(3y)8.49%
ROA(5y)3.43%
ROE(3y)10.82%
ROE(5y)4.36%
ROIC(3y)6.85%
ROIC(5y)N/A
ROICexc(3y)377.15%
ROICexc(5y)N/A
ROICexgc(3y)694.38%
ROICexgc(5y)N/A
ROCE(3y)8.08%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y140.57%
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y-0.6%
F-ScoreN/A
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.66
Quick Ratio 4.66
Altman-Z N/A
F-ScoreN/A
WACC7.54%
ROIC/WACC1.37
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.83%
EPS 3Y64.44%
EPS 5YN/A
EPS Q2Q%20.25%
EPS Next Y14.65%
EPS Next 2Y15.96%
EPS Next 3Y13.87%
EPS Next 5Y-10.22%
Revenue 1Y (TTM)12.4%
Revenue growth 3Y22.38%
Revenue growth 5Y33.57%
Sales Q2Q%13.98%
Revenue Next Year12.66%
Revenue Next 2Y12.72%
Revenue Next 3Y12.41%
Revenue Next 5Y10.73%
EBIT growth 1Y110.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year39.16%
EBIT Next 3Y18%
EBIT Next 5Y13.98%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

KANZHUN LTD - ADR / BZ Fundamental Analysis FAQ

What is the fundamental rating for BZ stock?

ChartMill assigns a fundamental rating of 6 / 10 to BZ.


Can you provide the valuation status for KANZHUN LTD - ADR?

ChartMill assigns a valuation rating of 5 / 10 to KANZHUN LTD - ADR (BZ). This can be considered as Fairly Valued.


How profitable is KANZHUN LTD - ADR (BZ) stock?

KANZHUN LTD - ADR (BZ) has a profitability rating of 7 / 10.


What is the expected EPS growth for KANZHUN LTD - ADR (BZ) stock?

The Earnings per Share (EPS) of KANZHUN LTD - ADR (BZ) is expected to grow by 14.65% in the next year.